MANNKIND CORP·4

Nov 15, 6:11 PM ET

Kendall David M 4

4 · MANNKIND CORP · Filed Nov 15, 2018

Insider Transaction Report

Form 4
Period: 2018-11-14
Kendall David M
Chief Medical Officer
Transactions
  • Award

    Common Stock, $0.01 Par Value

    2018-11-14$1.77/sh+2,824$4,9982,824 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION